Ahuja (2023) Berotralstat for the prophylaxis of hereditary angioedema Realworld evidence data from the United.pdf
Avhandling_Linda_Sundler_Bjo_rkman.pdf
Banerji (2021) - BOD - Insights-into-the-treatment-burden.pdf
Betschel (2019) The International Canadian HAE guidelines.pdf
Busse (2022) Specific targeting of plasma.pdf
Caballero (2012) - International consensus and practical guidelines gynecological.pdf
Caballero (2021) - Treatment of Hereditary Angioedema.pdf
Cassano et al (2021) Angioedema associated with .pdf
Christiansen (2024) ODT of HAE attacks - patient reported utilization.pdf
Cicardi (2010) Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema - N_Engl_J_Med.pdf
Cicardi M (2010) Acquired Angiooedema.pdf
Craig (2018) Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency - Ann Allergy Asthma Immunol.pdf
EMJ Interview March 2024 - Padmalal Gurugama and David Launay.pdf
Farkas (2021) APeX-S.pdf
Geba (2021) Hereditary-angioedema-patients-would-prefer-newer-generation-oral-prophylaxis.pdf
Gower (2023) - TRANS - Considerations for transition from subcutaneous to oral prophylaxis in HAE.pdf
Gramstad 2023 (003).pdf
Grivčeva-Panovska - Hereditary angioedema due to C1-inhibitor deficiency in Macedonia.pdf
Guryanova et al  - HAE due to C1 inhibitor deficiency in Belarus.pdf
HAE info from 4 swedish sources.pdf
Huilaja L (2024) Finland incidence, prevalence.pdf
Kiani-Alikhan APeX-2 Part 3 Manuscript JACI In Practice.pdf
Lumry (2024) - TRANS - Expert panel review on patients HAE switch from attenuated androgens to oral prophylactic therapy - Allergy Asthma Proc.pdf
Magerl (2024) - BOD - Frontiers in Medicine - Current Situation of HAE in Germany.pdf
Maurer (2022) WAO:EAACI guidelines.pdf
Maurer - The Icatibant Outcome Survey.pdf
Nordenfeldt 2017 _dissertation.pdf
Nordenfelt (2016) HAE in Sweden Natioonal cohort.pdf
Ohsawa (2020) APeX-J 24-week.pdf
Orladeyo SmPC.pdf
Pagnier (2024) Pediatric Allergy Immunology - HAE in children  Review and practical perspective for.pdf
Peter (2023) - TRANS - APeX-S Androgen Subset Manuscript WAO Journal.pdf
Peter (2023) - TRANS - Switch AA to Bero in Apex-S.pdf
Peter et al. APeX-S Androgen Subset Manuscript WAO Journal Nov 2023.pdf
Prior N (2012) - Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL)- Spanish multi-centre research project.pdf
Raasch (2023) - BOD - of HAE Diagnosis_WAOJ.pdf
Radojicic (2021) - BOD - Patient-perspectives-on-the-treatme.pdf
Reshef (2020)EAACI APeX-S Long-term Effectiveness of Berotralstat.pdf
Riedl (2021) - BOD - Physician-and-patient-perspectives-.pdf
Riedl (2023) - TRANS - AAAI - APeX-S Switch Manuscript.pdf
Sarkar et al (2022) - HAE often misdiagnosed and mistreated.pdf
Sundler Björkman (2022)  - Comorbidities in hereditary angioedema A population‐based cohort.pdf
Sundler Björkman (2022) Trends in treatement of HAE in Sweden.pdf
Wedner (2021) APeX-2.pdf
Zanichelli (2016) Misdiagnosis trends in patients with HAE.pdf
Zarnowski - Leipzig.pdf
Zuraw (2020) APeX-2 24-week.pdf
